| Financial Year |
March 31 2023 |
| Monetary Funds |
114,066,682.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
29,668,921.04 |
| Accounts Receivable |
1,003,634,467.44 |
| Advances to Suppliers |
88,874,169.63 |
| Other Receivables |
107,502,931.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
289,845,087.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,656,139.66 |
| Total Current Assets |
1,668,578,088.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
936,047,115.00 |
| Under-construction Projects |
310,894,680.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
438,379,088.97 |
| R&D expenses |
-- |
| Goodwill |
492,984,146.11 |
| Long-Term Deferred and Prepaid Expenses |
11,854,121.95 |
| Deferred Income Tax Assets |
23,545,395.16 |
| Other Non-Current Assets |
21,812,591.81 |
| Sub-Total of Non-Current Assets |
2,235,567,139.13 |
| Total Assets |
3,904,145,227.78 |
| Short-Term Loans |
611,280,549.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
784,041,334.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,677,537.01 |
| Taxes Payable |
63,997,781.60 |
| Interest Payable |
1,858,237.22 |
| Dividend Payable |
-- |
| Other payables |
196,711,451.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
488,713,682.70 |
| Other Current Liabilities |
562,692,947.94 |
| Sub-Total of Current Liabilities |
2,841,124,750.56 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
37,977,423.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
17,761,947.39 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
119,357,266.37 |
| Total Liabilities |
2,960,482,016.93 |
| Paid-In Capital(Or Share Stock) |
432,000,000.00 |
| Capital Surplus |
254,169,229.21 |
| Surplus Reserve |
75,580,396.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
216,581,133.34 |
| Minority Stockholder's Interest |
178,250,864.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
765,412,346.74 |
| Owner's Equity（Stockholder's Equity） |
943,663,210.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,904,145,227.78 |
